Autopsy report · NCT02626663
The Role of Microparticles as a Biomarker
Cause of deathStaffing, sites or logistics, also funding or business
“PI left the University, sponsor pulled funding”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- University of Rochester
- Sponsor type
- University, hospital or other
- Conditions
- Atypical Hemolytic Uremic Syndrome; Thrombotic Thrombocytopenic Purpura; Microparticles; Microangiopathic Hemolytic Anemia
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Once Versus Twice Daily Iron Supplementation in Pregnant Women
“Lack of funds, PI left University” - Pulse Wave Analysis in Advanced Heart Failure
“PI left University” - Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
“Funding and PI leaving institution” - Endovascular Revascularization of Symptomatic Chronically Occluded Internal Carotid Artery
“Study is not funded, PI has left the institution” - N2O for Acute Suicidality and Depression in the ED
“PI has left the university”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.